Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures

Nat Biotechnol. 2020 Jul;38(7):789-791. doi: 10.1038/s41587-020-0577-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antibody-Dependent Enhancement*
  • Betacoronavirus / physiology
  • COVID-19
  • COVID-19 Vaccines
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / virology*
  • Disease Models, Animal
  • Humans
  • Pandemics
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / virology*
  • Primates
  • SARS Virus / physiology
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / metabolism
  • Viral Vaccines / immunology
  • Virus Diseases / immunology
  • Virus Diseases / virology

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Viral Vaccines